scispace - formally typeset
R

Richard J. Robbins

Researcher at Cornell University

Publications -  48
Citations -  3872

Richard J. Robbins is an academic researcher from Cornell University. The author has contributed to research in topics: Thyroid cancer & Transplantation. The author has an hindex of 26, co-authored 48 publications receiving 3782 citations. Previous affiliations of Richard J. Robbins include Memorial Sloan Kettering Cancer Center & Yale University.

Papers
More filters
Journal ArticleDOI

Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy

TL;DR: This paper provides the first evidence of such reorganization of a hippocampal seizure focus in human temporal lobe epilepsy (TLE), which involves the selective loss of somatostatin and neuropeptide Y immunoreactive interneurons, and axonal sprouting of other neuropePTide Y neurons and dynorphin-A immunore active granule cells.
Journal ArticleDOI

Unilateral Transplantation of Human Fetal Mesencephalic Tissue into the Caudate Nucleus of Patients with Parkinson's Disease

TL;DR: Although the case patients with severe Parkinson's disease continued to be disabled by their disease, unilateral intracaudate grafts of fetal tissue containing dopamine diminished the symptoms and signs of parkinsonism during 18 months of evaluation.
Journal ArticleDOI

Aging and hypothalamic-pituitary-adrenal response to challenge in humans

TL;DR: Interest in possible age-related changes in homeostatic regulation, and in HPA functioning in particular, has been stimulated by the fact that men and women who are 65 and over represent one of the fastest growing segments of the population.
Journal ArticleDOI

Correcting Common Errors in Identifying Cancer-Specific Serum Peptide Signatures†

TL;DR: A peptidomics platform that couples magnetics-based, automated solid-phase extraction of small peptides with a high-resolution MALDI-TOF mass spectrometric readout is developed and it is found that sera from thyroid cancer patients can be distinguished from healthy controls based on an array of 98 discriminant peptides.
Journal ArticleDOI

Bone Metastases from Thyroid Carcinoma: Clinical Characteristics and Prognostic Variables in One Hundred Forty-Six Patients

TL;DR: In a subgroup of patients in which histologic specimens were available and were reviewed, Hurthle cell carcinoma was the most favorable histologic subtype for survival with the undifferentiated subtype being the worst.